The microbiome-gerogene axis: a new frontier in precision geromedicine
Open Access
- 8 May 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging
- Vol. 7, 1794192
Abstract
Aging is increasingly recognized as a biologically heterogeneous process arising from dynamic interactions among genetic programs, environmental exposures, and adaptive physiological responses. Within the geroscience framework, conserved hallmarks, including genomic instability, epigenetic alterations, mitochondrial dysfunction, chronic inflammation, cellular senescence, and dysbiosis, capture the systems-level nature of age-related decline. Parallel to this framework, the concept of gerogenes defines coordinated molecular programs that actively drive biological aging when persistently engaged, counterbalanced by gerosuppressive pathways that preserve resilience. Here, we synthesize evidence supporting a unifying microbiome-gerogene axis in which the gut microbiome functions as an upstream, modifiable regulator of molecular aging trajectories. Age-associated microbial remodeling leads to loss of beneficial metabolic functions, including short-chain fatty acid production, bile acid transformation, and mitochondrial-supportive co-metabolism, with downstream effects on epithelial barrier integrity, immune homeostasis, and tissue repair. Integrated multi-omics studies link these microbial changes to host transcriptional, epigenomic, proteomic, and metabolomic signatures of biological aging, enabling mechanistic insights beyond taxonomic associations. Immune aging represents a major convergence point of microbiome-gerogene crosstalk, as dysbiosis driven barrier dysfunction and microbial translocation reinforce inflammaging, immunosenescence, and senescence-associated signaling networks. In parallel, microbial metabolites interface with epigenetic regulation, mitochondrial quality control, circadian biology, and gut-brain-immune communication, extending microbial influence to systemic and neurodegenerative aging processes. Building on this mechanistic foundation, we propose the microbiome-gerogene axis as an integrative framework for precision geromedicine, linking lifestyle exposures to intracellular aging programs and informing biomarker discovery and personalized interventions aimed at extending healthspan rather than treating late-stage disease.Keywords
This publication has 151 references indexed in Scilit:
- Engineering microbial metabolites to modulate tumor immunity and advance cancer immunotherapyDiscover Immunity, 2026
- Bidirectional interactions between circadian rhythms and the gut microbiomeApplied Microbiology and Biotechnology, 2025
- Epigenetic Regulation of Aging and its RejuvenationMedcomm, 2025
- Unraveling the Gut‐Brain‐Immune Interplay in Herpes Simplex Virus‐Associated NeurodegenerationJournal of Medical Virology, 2025
- Aging through the lens of the gut microbiome: Challenges and therapeutic opportunitiesArchives of Gerontology and Geriatrics Plus, 2025
- Emerging Roles of Modern Lifestyle Factors in Microbiome Stability and FunctionalityCurrent Clinical Microbiology Reports, 2025
- Promotion of Healthy Aging Through the Nexus of Gut Microbiota and Dietary PhytochemicalsAdvances in Nutrition, 2025
- Harnessing gut microbiota for longevity: Insights into mechanisms and genetic manipulationiMetaOmics, 2024
- Geroprotective interventions converge on gene expression programs of reduced inflammation and restored fatty acid metabolismGeroScience, 2023
- Age-related changes in intestinal immunity and the microbiomeJournal of Leukocyte Biology, 2020